Literature DB >> 26782783

Comparative Modeling, Molecular Docking, and Revealing of Potential Binding Pockets of RASSF2; a Candidate Cancer Gene.

Sonia Kanwal1, Farrukh Jamil1, Ahmad Ali1, Sheikh Arslan Sehgal2,3,4.   

Abstract

RASSF2, potential tumor suppressor gene, acts as a KRAS-specific effectors protein and may promote apoptosis and cell cycle arrest. It stabilizes STK3/MST2 by protecting it from proteasomal degradation. RASSF2 plays a significant role against the inhibition of cancer. MODELLER (9v15) and online servers (I-Tasser, SwissModel, 3D-JigSaw, ModWeb) were utilized to generate 3D structures of the RASSF2 based on homology modeling. A comparison between models predicted by MODELLER (9v15) and Web servers had been checked through utilized evaluation tools. The most potent model for RASSF2 was analyzed and selected for molecular docking studies. The binding pockets were revealed for binding studies through Site Hound. AutoDock Vina and AutoDock4 were utilized for molecular docking, and the attempt of this experiment was to identify the ligands for RASSF2. The selected compounds may act as regulators and regulate the normal activity of RASSF2. It was also analyzed and observed that the selected compounds showed least binding energy and high-affinity binding in predicted top binding domain. The determination of protein function is based on accurate identification of binding sites in protein structures. The binding site is known, and it may allow the ligand type and protein function to be determined by performing in silico and experimental procedures. The detection, comparison, and analysis of binding pockets are pivotal to drug discovery. It proposed that predicted structure is reliable for the structural insights and functional studies. The predicted binding pockets may lead to further analysis (drug discovery), used against cancer study.

Entities:  

Keywords:  Binding domains; Cancer; Homology modeling; Molecular docking analyses; RASSF2

Mesh:

Substances:

Year:  2016        PMID: 26782783     DOI: 10.1007/s12539-016-0145-z

Source DB:  PubMed          Journal:  Interdiscip Sci        ISSN: 1867-1462            Impact factor:   2.233


  11 in total

1.  Improving enzyme activity of glucosamine-6-phosphate synthase by semi-rational design strategy and computer analysis.

Authors:  Piwu Li; Kang Li; Xu Li; Fei Zhao; Ruiming Wang; Junqing Wang
Journal:  Biotechnol Lett       Date:  2020-06-29       Impact factor: 2.461

2.  The potential mechanism of Bupleurum against anxiety was predicted by network pharmacology study and molecular docking.

Authors:  Han-Biao Wu; Yu-Gang Xiao; Ji-Sheng Chen; Zhi-Kun Qiu
Journal:  Metab Brain Dis       Date:  2022-04-02       Impact factor: 3.584

3.  Pharmacoinformatics, Adaptive Evolution, and Elucidation of Six Novel Compounds for Schizophrenia Treatment by Targeting DAOA (G72) Isoforms.

Authors:  Sheikh Arslan Sehgal
Journal:  Biomed Res Int       Date:  2017-01-19       Impact factor: 3.411

4.  In-Silico Characterization and in-Vivo Validation of Albiziasaponin-A, Iso-Orientin, and Salvadorin Using a Rat Model of Alzheimer's Disease.

Authors:  Mahmood Rasool; Arif Malik; Sulayman Waquar; Qura Tul-Ain; Tassadaq H Jafar; Rabia Rasool; Aasia Kalsoom; Muhammad A Ghafoor; Sheikh A Sehgal; Kalamegam Gauthaman; Muhammad I Naseer; Mohammed H Al-Qahtani; Peter N Pushparaj
Journal:  Front Pharmacol       Date:  2018-08-02       Impact factor: 5.810

5.  In Silico identification of angiotensin-converting enzyme inhibitory peptides from MRJP1.

Authors:  Rana Adnan Tahir; Afsheen Bashir; Muhammad Noaman Yousaf; Azka Ahmed; Yasmine Dali; Sanaullah Khan; Sheikh Arslan Sehgal
Journal:  PLoS One       Date:  2020-02-03       Impact factor: 3.240

Review 6.  Artificial intelligence and big data facilitated targeted drug discovery.

Authors:  Benquan Liu; Huiqin He; Hongyi Luo; Tingting Zhang; Jingwei Jiang
Journal:  Stroke Vasc Neurol       Date:  2019-11-07

7.  Pharmacoinformatic and molecular docking studies reveal potential novel antidepressants against neurodegenerative disorders by targeting HSPB8.

Authors:  Sheikh Arslan Sehgal; Shazia Mannan; Sannia Ali
Journal:  Drug Des Devel Ther       Date:  2016-05-06       Impact factor: 4.162

Review 8.  Current Therapeutic Molecules and Targets in Neurodegenerative Diseases Based on in silico Drug Design.

Authors:  Sheikh Arslan Sehgal; Mirza A Hammad; Rana Adnan Tahir; Hafiza Nisha Akram; Faheem Ahmad
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

9.  Homology Model and Docking-Based Virtual Screening for Ligands of Human Dyskerin as New Inhibitors of Telomerase for Cancer Treatment.

Authors:  Romina Gabriela Armando; Diego Luis Mengual Gómez; Ezequiel Ivan Juritz; Pablo Lorenzano Menna; Daniel Eduardo Gomez
Journal:  Int J Mol Sci       Date:  2018-10-18       Impact factor: 5.923

10.  TAF1A and ZBTB41 serve as novel key genes in cervical cancer identified by integrated approaches.

Authors:  Mingyuan Wang; Jingnan Liao; Jinjin Wang; Mingming Qi; Kangkai Wang; Wei Wu
Journal:  Cancer Gene Ther       Date:  2020-12-12       Impact factor: 5.987

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.